Pennant Group, Inc. (PNTG) research
Pennant Group, Inc.- Sector
- Health Care
- Last price
- $39.24
- As of
Pennant Group, Inc. (PNTG): 5 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-05.
As of . Source: SEC EDGAR filings for PNTG. Method and limitations.
Share the PNTG intelligence card
See the full PNTG dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for PNTG on one page. Preview it with sample data, then open it live with a free account.
Preview the PNTG dossierActive signals for PNTG
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +112% to PNTG (2026Q2)
- mediumEARNINGS_BEAT
Q2-2026: Beat consensus by 7.0%, EPS $0.36 vs $0.3366 estimate
- highCONSENSUS_BUY
4 tracked funds increased PNTG this 2026Q1 - institutional consensus
- highINSTITUTIONAL_SURGE
MILLENNIUM MANAGEMENT LLC added +52% to PNTG (2026Q1)
- highINSTITUTIONAL_EXIT
D. E. Shaw & Co., Inc. cut 55% of PNTG (2026Q1)
FREE, NO ACCOUNT
Every signal on PNTG, as it fires
You are seeing 5 of 11 signals recorded on PNTG since 2026-05-26.
The five above landed across 3 days. The other 6 were recorded on 2 other days. 6 of the 11 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in PNTG (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLCCUSIP 70805E109 · 2026Q2 | $4.6M | 0.00% | , |
| D. E. Shaw & Co., Inc.CUSIP 70805E109 · 2026Q2 | $4.6M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 70805E109 · 2026Q2 | $2.9M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 70805E109 · 2026Q2 | $2.7M | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 70805E109 · 2026Q2 | $1.8M | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, PNTG
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
PNTG against its peers
PNTG's operating margin of 5.5% ranks in the 56th percentile of 25 Health Care sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-01-02.
| Metric | PNTG | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 948M USD | 781M USD | 60 | 25 |
| Gross margin | n/a | 64.7% | n/a | 16 |
| Operating margin | 5.5% | 1.4% | 56 | 25 |
| Net margin | 3.1% | 0.2% | 56 | 25 |
| Return on equity | 7.9% | 0.2% | 67 | 25 |
| P / E | 46.7x | 38.8x | 63 | 11 |
Peers (25): AMN, CNMD, CERT, USPH, OMCL, OMDA, ATEC, TNDM, STAA, GDRX, ALHC, IRMD, CSTL, TDOC, PRCT, XRAY, NVCR, LMAT, PGNY, INSP, BVS, HSTM, SEM, MD, TALK. Fiscal periods ending between 2025-12-31 and 2026-01-02. Every figure is one full fiscal year read from one annual filing (PNTG: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more PNTG signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to PNTGand get the insider, 13F, options, and confluence read in one view.